Clinical trial
Cyclophosphamide and Fludarabine to Treat Lupus Nephritis
NCT00001676 · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH · Completed
Key facts
| NCT number | NCT00001676 |
|---|---|
| Title | Cyclophosphamide and Fludarabine to Treat Lupus Nephritis |
| Official title | Combination of Cyclophosphamide and Fludarabine for Lupus Nephritis: Tolerance, Toxicity, Efficacy and Effects on B and T Lymphocyte Regeneration |
| Lead sponsor | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Glomerulonephritis, Lupus Nephritis, Systemic Lupus Erythematosus |
| Intervention type | Drug |
| Interventions | SQ Fludarabine |
| Enrollment | 15 |
| Start date | Jan 1, 1998 |
| Completion | Nov 1, 2002 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: